Abstract
Endothelin receptors (ETA and ETB) mediate responses to ET-1. ETB receptor function seems to differ between a similarly sized arterial and venous pair, the rat vena cava (RVC) and rat thoracic aorta (RA). ETB receptors mediate RVC contraction directly, but it is unclear whether ETB receptors mediate contraction in RA. Because of these apparent differences in ETB receptor-mediated vascular contraction, we hypothesize that relaxant ETB-receptor mechanisms in RVC would be different from those in RA. RA and RVC rings were isolated from rats for measurement of isometric contraction. When contracted with prostaglandin F-2α (PGF-2α) (20 μM), the ETB receptor agonist sarafotoxin-6c (S6c) (100 nM) significantly relaxed RA and RVC. Nω-Nitro-l-arginine (LNNA) (100 μM) or endothelial denudation abolished relaxation to S6c in RA. By contrast, S6c-induced relaxation of RVC was attenuated but not abolished by LNNA and endothelial denudation. RVC (PGF-2α-contracted) relaxed to low concentrations of ET-1, whereas under the same conditions RA responded with contraction. ET-1-induced relaxation in RA was observed only with ETA receptor blockade. Vessels from dopamine-β-hydroxylase-ETB transgenic rats, which lack functional ETB receptors in the vasculature, were also used. RVC (PGF-2α-contracted) from these rats did not relax to ET-1. Thus, although both RA and RVC possess endothelial relaxant ETB receptors, RA and RVC differ in that relaxant ETB receptors may also be present in smooth muscle of RVC. Moreover, the mechanisms of endothelial cell ETB receptor-mediated relaxation in RA and RVC are not the same.
Footnotes
-
This work was supported by the National Institutes of Health National Heart, Lung, and Blood Institute [Grant PO1-HL70687].
-
Article, publication date, and citation information can be found at http://jpet.aspetjournals.org.
-
doi:10.1124/jpet.108.145953.
-
ABBREVIATIONS: ET, endothelin; S6c, sarafotoxin 6c; IRL1620, succinyl-(Glu9,Ala11,15)-ET-1-(8-21); RVC, rat vena cava; RA, rat thoracic aorta; (+/+), homozygous littermate to (sl/sl) rat; (sl/sl), homozygous spotting lethal ETB receptor-deficient rat; PSS, physiological salt solution; PECAM, platelet/endothelial cell adhesion molecule; DAPI, 4,6-diamidino-2-phenylindole; NE, norepinephrine; PE, phenylephrine; PGF-2α, prostaglandin F-2α; BQ-788, N-cis-2,6-dimethylpiperidinocarbonyl-L-γ-methylleucyl-d-1-methoxycarbonyltryptophanyl-d-norleucine; dH2O, distilled water; LNNA, Nω-nitro-l-arginine; ACh, acetylcholine.
- Received September 26, 2008.
- Accepted March 16, 2009.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|